Clarian Health and the Indiana University School of Medicine want their planned neurosciences hub to become a destination
for patients suffering
from brain, nerve and mental maladies—and for the government and industry research dollars that can
fuel advances in care.
The Health & Hospital Corporation of Marion County got good news in its first round of borrowing to finance a new Wishard
Hospital: so far, it is paying less than planned.
A Lebanon-based startup wants to build a call center here and add up to 300 jobs, but state and local officials are struggling
with a big obstacle to keeping the company here.
Polymer Technology Systems Inc., a small Indianapolis-based maker of handheld blood monitors, has gone to court to fight
a competitor more than 100 times its size: Roche Diagnostics Corp.
Health insurer WellPoint is blaming the Great Recession and rising medical costs for its planned 39 percent rate increase
for some California customers of its Anthem Blue Cross plan. But Health and Human Services Secretary Kathleen Sebelius isn’t
buying the explanation proffered in a letter delivered to her Thursday.
The Indianapolis-based health insurer says a shift in demographics and rising medical costs have led to its planned 39 percent
rate hike for some California customers.
A report set to be released Wednesday by local life sciences industry group BioCrossroads says Indiana companies providing
contract pharmaceutical research and manufacturing services are weathering the economic downturn and are growing.
Pharmacy giant CVS will pay $1.95 million and verify that all of its pharmacists are licensed in Indiana to settle a state
complaint that pharmacists with expired licenses dispensed prescriptions for several years at two of its drugstores.
VoCare Inc. wants $4 million in cash and tax incentives to open headquarters and call center it says could employ 300 people.
The Health & Hospital Corp. of Marion County got good news in its first round of borrowing to finance a new Wishard
hospital: The cost is less than expected.
Health care real estate has survived the nation’s weak economy better than most sectors, and some owners and developers
think it’s positioned to thrive.
WellPoint Inc. chief financial officer Wayne DeVeydt said President Obama’s Federal Trade Commission is unlikely to approve
mergers among the biggest insurers.
Eli Lilly and Co. CEO John Lechleiter’s total compensation increased $4.1 million in 2009.
Cardinal Health notified the state on Feb. 3 that it laid off 37 workers at the end of January and plans to lay off 12 more
effective April 3.
Employer activism is on the rise when it comes to keeping hospitals honest in their negotiations with health insurers.
Executives at Indianapolis-based WellPoint say more employers are airing their displeasure when hospital
systems ask for double-digit reimbursement increases.
The uncertainty of health care reform and a bad economy curtailed venture capital flow in 2009.
Mississippi will receive $18.5 million from Indianapolis-based drugmaker Eli Lilly and Co. as part of a settlement over claims
the company promoted the anti-psychotic Zyprexa for ailments it was not federally approved to treat.
Batesville maker of hospital equipment meets analysts’ expectations, then raises full-year profit forecast.
Larry Glasscock will step down March 1 as WellPoint CEO Angela Braly takes over leadership of the company’s board. She replaced
Glasscock as CEO on June 1, 2007.
Larry Glasscock will retire as chairman of WellPoint Inc.’s board, the Indianapolis-based health insurer said early Wednesday.
Company CEO Angela Braly will assume the position March 1.
